StockDriftsStockDriftsIlyang Pharmaceutical (007570) has 31 disclosed insider purchases and 0 disclosed disposals on record, filed by 3 distinct insiders. Together those filings cover ₩433M ($301K) in reported transaction value. The earliest filing StockDrifts holds for Ilyang Pharmaceutical is dated 2024-07-24; the most recent is 2026-05-28. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is -2.26%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-07-30 | BUY | 수증 | 정유석 Jeong Yoo-seok | CEO and President | 1.7M | ₩8,130 | +3.1% | ₩13.8B ($9.6M) |
| 2026-07-30 | SELL | 증여 | 정도언 Jeong Do-eon | - | -1.7M | ₩8,130 | -3.1% | ₩13.8B ($9.6M) |
| 2026-05-28 | BUY | Market Buy | 정연찬 Yeonchan Jeong | Managing Director | 1.1K | ₩9,080 | +0.0% | ₩10M ($7K) |
| 2026-05-27 | BUY | Market Buy | 송화준 Song Hwajun | moving | 2.0K | ₩9,310 | -2.5% | ₩19M ($13K) |
| 2026-04-01 | BUY | 신규선임 | 송화준 Song Hwajun | moving | 60 | ₩11,180 | +3.2% | ₩671K ($466) |
| 2025-07-08 | BUY | 기타 | 정도언 Jeong Do-eon | - | 50 | - | - | - |
| 2025-05-10 | SELL | 임원퇴임 | 서원철 Seo Won-cheol | Managing Director | -70 | ₩12,850 | -1.6% | ₩900K ($625) |
| 2024-10-18 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 1.1K | ₩13,240 | -1.4% | ₩15M ($10K) |
| 2024-10-17 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 1.5K | ₩12,980 | +0.5% | ₩19M ($14K) |
| 2024-10-16 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 1.5K | ₩13,080 | -0.2% | ₩20M ($14K) |
| 2024-10-15 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 1.5K | ₩12,950 | +0.8% | ₩19M ($13K) |
| 2024-10-14 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 1.0K | ₩12,890 | +1.2% | ₩13M ($9K) |
| 2024-10-11 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 1.0K | ₩12,920 | +1.0% | ₩13M ($9K) |
| 2024-10-10 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 500 | ₩12,910 | +1.1% | ₩6M ($4K) |
| 2024-10-07 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 1.5K | ₩12,970 | +0.6% | ₩19M ($14K) |
| 2024-10-04 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 1.0K | ₩13,010 | +0.3% | ₩13M ($9K) |
| 2024-09-30 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 1.0K | ₩13,060 | -0.1% | ₩13M ($9K) |
| 2024-09-11 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 300 | ₩13,180 | -1.0% | ₩4M ($3K) |
| 2024-09-09 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 500 | ₩13,060 | -0.1% | ₩7M ($5K) |
| 2024-09-09 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 500 | ₩13,060 | -0.1% | ₩7M ($5K) |
| 2024-09-09 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 500 | ₩13,060 | -0.1% | ₩7M ($5K) |
| 2024-09-06 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 760 | ₩13,060 | -0.1% | ₩10M ($7K) |
| 2024-09-06 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 88 | ₩13,060 | -0.1% | ₩1M ($798) |
| 2024-09-06 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 1 | ₩13,060 | -0.1% | ₩13K ($9) |
| 2024-09-06 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 501 | ₩13,060 | -0.1% | ₩7M ($5K) |
| 2024-09-06 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 150 | ₩13,060 | -0.1% | ₩2M ($1K) |
| 2024-08-08 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 1.5K | ₩14,770 | -11.7% | ₩22M ($15K) |
| 2024-08-07 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 1.5K | ₩14,360 | -9.1% | ₩22M ($15K) |
| 2024-08-02 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 1.5K | ₩14,100 | -7.5% | ₩21M ($15K) |
| 2024-08-01 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 1.5K | ₩14,270 | -8.6% | ₩21M ($15K) |
| 2024-07-31 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 1.5K | ₩13,950 | -6.5% | ₩21M ($15K) |
| 2024-07-30 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 1.5K | ₩13,820 | -5.6% | ₩21M ($14K) |
| 2024-07-29 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 1.5K | ₩13,840 | -5.7% | ₩21M ($14K) |
| 2024-07-26 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 1.5K | ₩13,770 | -5.2% | ₩21M ($14K) |
| 2024-07-25 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 1.5K | ₩13,710 | -4.8% | ₩21M ($14K) |
| 2024-07-24 | BUY | Market Buy | 정유석 Jeong Yoo-seok | CEO and President | 1.5K | ₩13,780 | -5.3% | ₩21M ($14K) |
| 2020-07-02 | BUY | 기타 | 정도언 Jeong Do-eon | - | 50 | - | - | - |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Ilyang Pharmaceutical. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.